LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0.1 | 0.1 | 37.3 | 26.9 | 49.6 | 156.7 | 59.6 | 13.2 | 0.3 | - | 343.9 |
1 | 0.1 | - | 2.9 | 3.6 | 3.7 | 57.5 | 17.3 | 0.9 | - | - | 86.0 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 0.5 |
1 | 0.3 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 16.4 |
1 | 93.6 |
Number of post synapses: 6191
Number of pre synapses: 1548
Number of output connections: 5053
Coverage factor: 1.7
Columnar completeness: 0.46
Area completeness: 0.48
Cell size (columns): 31
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVP12 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Mi10 (R) | ACh | 686 | 38.1 | 11.2% | 11.2% |
1 | Dm11 (R) | Glu | 576 | 32.0 | 9.4% | 20.6% |
2 | Mi15 (R) | ACh | 564 | 31.3 | 9.2% | 29.8% |
3 | Tm5c (R) | Glu | 402 | 22.3 | 6.6% | 36.3% |
4 | Mi4 (R) | GABA | 315 | 17.5 | 5.1% | 41.5% |
5 | MeLo3b (R) | ACh | 309 | 17.2 | 5.0% | 46.5% |
6 | MeTu3c (R) | ACh | 292 | 16.2 | 4.8% | 51.3% |
7 | Mi9 (R) | Glu | 183 | 10.2 | 3.0% | 54.3% |
8 | Mi16 (R) | GABA | 179 | 9.9 | 2.9% | 57.2% |
9 | MeVC4a (L) | ACh | 177 | 9.8 | 2.9% | 60.1% |
10 | Dm8a (R) | Glu | 174 | 9.7 | 2.8% | 62.9% |
11 | Tm12 (R) | ACh | 164 | 9.1 | 2.7% | 65.6% |
12 | Cm4 (R) | Glu | 133 | 7.4 | 2.2% | 67.7% |
13 | Cm34 (R) | Glu | 120 | 6.7 | 2.0% | 69.7% |
14 | MeTu3b (R) | ACh | 115 | 6.4 | 1.9% | 71.6% |
15 | Tm5b (R) | ACh | 85 | 4.7 | 1.4% | 73.0% |
16 | Dm8b (R) | Glu | 76 | 4.2 | 1.2% | 74.2% |
17 | aMe5 (R) | ACh | 74 | 4.1 | 1.2% | 75.4% |
18 | MeTu3a (R) | ACh | 73 | 4.1 | 1.2% | 76.6% |
19 | Dm-DRA2 (R) | Glu | 72 | 4.0 | 1.2% | 77.8% |
20 | Dm-DRA1 (R) | Glu | 69 | 3.8 | 1.1% | 78.9% |
21 | Cm23 (R) | Glu | 64 | 3.6 | 1.0% | 79.9% |
22 | Dm2 (R) | ACh | 64 | 3.6 | 1.0% | 81.0% |
23 | MeVP6 (R) | Glu | 62 | 3.4 | 1.0% | 82.0% |
24 | MeLo6 (R) | ACh | 50 | 2.8 | 0.8% | 82.8% |
25 | MeVC2 (L) | ACh | 50 | 2.8 | 0.8% | 83.6% |
26 | MeVC4b (L) | ACh | 46 | 2.6 | 0.8% | 84.4% |
27 | Cm1 (R) | ACh | 45 | 2.5 | 0.7% | 85.1% |
28 | Dm20 (R) | Glu | 40 | 2.2 | 0.7% | 85.8% |
29 | Cm21 (R) | GABA | 36 | 2.0 | 0.6% | 86.4% |
30 | MeVC27 (L) | unclear | 36 | 2.0 | 0.6% | 86.9% |
31 | MeVC11 (L) | ACh | 35 | 1.9 | 0.6% | 87.5% |
32 | Cm31a (R) | GABA | 34 | 1.9 | 0.6% | 88.1% |
33 | MeVPLo2 (R) | ACh | 31 | 1.7 | 0.5% | 88.6% |
34 | MeVC3 (L) | ACh | 29 | 1.6 | 0.5% | 89.0% |
35 | MeVP46 (R) | Glu | 29 | 1.6 | 0.5% | 89.5% |
36 | Cm3 (R) | GABA | 24 | 1.3 | 0.4% | 89.9% |
37 | Cm20 (R) | GABA | 21 | 1.2 | 0.3% | 90.2% |
38 | TmY21 (R) | ACh | 19 | 1.1 | 0.3% | 90.6% |
39 | MeTu1 (R) | ACh | 18 | 1.0 | 0.3% | 90.9% |
instance | NT | total connections | connections /#MeVP12 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Mi17 (R) | GABA | 733 | 40.7 | 14.3% | 14.3% |
1 | MeVP6 (R) | Glu | 457 | 25.4 | 8.9% | 23.3% |
2 | Mi16 (R) | GABA | 404 | 22.4 | 7.9% | 31.2% |
3 | Cm8 (R) | GABA | 336 | 18.7 | 6.6% | 37.7% |
4 | Mi15 (R) | ACh | 261 | 14.5 | 5.1% | 42.8% |
5 | Tm30 (R) | GABA | 252 | 14.0 | 4.9% | 47.8% |
6 | MeVC27 (L) | unclear | 250 | 13.9 | 4.9% | 52.6% |
7 | MeVP57 (R) | unclear | 197 | 10.9 | 3.9% | 56.5% |
8 | Cm10 (R) | GABA | 175 | 9.7 | 3.4% | 59.9% |
9 | Tm37 (R) | Glu | 166 | 9.2 | 3.2% | 63.2% |
10 | Cm3 (R) | GABA | 164 | 9.1 | 3.2% | 66.4% |
11 | Cm13 (R) | Glu | 149 | 8.3 | 2.9% | 69.3% |
12 | MeVP14 (R) | ACh | 134 | 7.4 | 2.6% | 71.9% |
13 | MeVPMe3 (R) | Glu | 127 | 7.1 | 2.5% | 74.4% |
14 | Cm15 (R) | GABA | 100 | 5.6 | 2.0% | 76.3% |
15 | Cm20 (R) | GABA | 78 | 4.3 | 1.5% | 77.9% |
16 | Cm12 (R) | GABA | 72 | 4.0 | 1.4% | 79.3% |
17 | aMe4 (R) | ACh | 58 | 3.2 | 1.1% | 80.4% |
18 | aMe17a (R) | Glu | 54 | 3.0 | 1.1% | 81.5% |
19 | aMe5 (R) | ACh | 54 | 3.0 | 1.1% | 82.5% |
20 | Mi9 (R) | Glu | 52 | 2.9 | 1.0% | 83.5% |
21 | Cm21 (R) | GABA | 37 | 2.1 | 0.7% | 84.2% |
22 | Tm5c (R) | Glu | 37 | 2.1 | 0.7% | 85.0% |
23 | Mi4 (R) | GABA | 36 | 2.0 | 0.7% | 85.7% |
24 | OA-AL2i4 (R) | OA | 36 | 2.0 | 0.7% | 86.4% |
25 | MeVPMe4 (R) | Glu | 35 | 1.9 | 0.7% | 87.1% |
26 | Cm29 (R) | GABA | 34 | 1.9 | 0.7% | 87.7% |
27 | Cm14 (R) | GABA | 33 | 1.8 | 0.6% | 88.4% |
28 | Cm28 (R) | unclear | 28 | 1.6 | 0.5% | 88.9% |
29 | MeTu4a (R) | ACh | 24 | 1.3 | 0.5% | 89.4% |
30 | MeVPMe13 (R) | ACh | 20 | 1.1 | 0.4% | 89.8% |
31 | Cm6 (R) | GABA | 18 | 1.0 | 0.4% | 90.1% |
32 | MeLo3b (R) | ACh | 18 | 1.0 | 0.4% | 90.5% |